Checkpoint immunotherapy rejects primary tumors without cDC1 cells or lasting immune memory
A new study has revealed that immune checkpoint blockade can drive the first wave of tumor rejection even when a ...
A new study has revealed that immune checkpoint blockade can drive the first wave of tumor rejection even when a ...
Cancer immunotherapy is entering a new phase in which the goal is no longer simply to “release the brakes” on ...
Cancer researchers are turning to an unexpected set of tools—sound waves, beams of light, electrical pulses, magnetic nanoparticles and carefully ...
Cancer immunotherapy has gained a hybrid new contender: a living cell engineered by fusing two immune-system specialists into one tumor-hunting ...
Cancer immunotherapy is entering a more controlled and technically sophisticated phase, according to a wide-ranging collection of studies and reviews ...
Mass General Brigham researchers have identified two genetic regulators that appear to drive the decline of cancer-fighting T cells in ...
Researchers at Purdue University have developed a small-molecule compound that could open a new route toward cancer immunotherapy by targeting ...
Zhou, Fiches, Wu and colleagues report that blocking the chromatin-regulating enzymes KDM5A and KDM5B can strengthen antitumor innate immune responses ...
Irvine, Calif., Aug. 20, 2026 — Immunotherapy has changed the outlook for many people with advanced cancer by turning the ...
Researchers at the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy have identified a potential way ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine